3009 E Renner Rd, #100
Richardson, TX 75082

Phone: 469-842-7392
Fax: 469-842-7438

Mon - Fri:
8:30AM - 4:30PM

Meet Dr. El-Nazer

Rasheda El-Nazer, MD

Board Certified Movement Disorders Neurologist

Rasheda El-Nazer, M.D., is a board certified neurologist and is a fellowship trained movement disorders specialist. She specializes in the evaluation, management and treatment of various movement disorders to include Parkinson Disease, Huntington’s chorea, tremor, dystonia, and ataxias to name a few. Dr El-Nazer is also passionate about both patient and medical trainee education as well as community outreach. She remains on as adjunct faculty at UT Southwestern Medical Center.

Dr. El-Nazer earned her medical degree at the Ross University School of Medicine. She completed a residency in neurology at Texas A&M, where she served as a chief resident in her final year. She gained advanced training through a fellowship in movement disorders at UT Southwestern.

Certified in neurology by the American Board of Psychiatry and Neurology, Dr. El-Nazer joined the UT Southwestern faculty in 2020 where she advanced to the level of Assistant Professor of Neurology and held leadership position as the Associate Fellowship Program Director.

Dr. El-Nazer serves on the board of the Dallas Area Parkinson Society and the North Texas Huntington’s Disease Society. She is a member of the American Academy of Neurology, the Movement Disorder Society, and the Huntington Study Group.

Her recent publications include coauthored chapters of Patient Selection Criteria for Deep Brain Stimulation for Dystonia and Practical Guide to Botulinum Toxin Injections.

Ross University School of Medicine
Texas A&M / Baylor Scott & White – Neurology Residency
University of Texas Southwestern – Movement Disorders Fellowship

American Academy of Neurology
Huntington Study Group
Movement Disorder Society

1. Feltrin F, Chopra R, Pouratian N, Elkurd M, El-Nazer R, Lanford L, Dauer W, Shah B. Focused Ultrasound Using a Novel Targeting Method. 2022 February.

2. El-Nazer R, Mahajan A, Chitnis S. An Online Education Method for Movement disorders during COVID-19: Opportunity and Experience. 2021 July; 36 (7); 1475-1480.

3. El-Nazer R, Adler CH, Beach TG, Belden CM, Artz J, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Zamrini E, Benge JF. Regional neuropathology distribution and verbal fluency impairments in Parkinson’s disease. Parkinsonism Related Disorders. 2019 Aug;65:73-78.

4. Lu G, Rao M, Zhu P, Liang B, El-Nazer RT, Fonkem E, Bhattacharjee MB, Zhu JJ. Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study. Front Neurol. 2019 Jan 31;10:42

5. Bolognini N, Vallar G, Casati C, Latif LA, El-Nazer R, Williams J, Banco E, Macea DD, Tesio L, Chessa C, Fregni F. Neurophysiological and behavioral effects of tDCS combined with constraint- induced movement therapy in poststroke patients. Neurorehabil Neural Repair. 2011 Nov-Dec;25(9):819-29. doi: 10.1177/1545968311411056. Epub 2011 Jul 29

6. Tadini L, El-Nazer R, Brunoni AR, Williams J, Carvas M, Boggio P, Priori A, Pascual-Leone A, Fregni F. Cognitive, mood, and electroencephalographic effects of noninvasive cortical stimulation with weak electrical currents. J ECT. 2011 Jun;27(2):134-40. doi: 10.1097/YCT.0b013e3181e631a8.

7. Zaghi S, de Freitas Rezende L, de Oliveira LM, El-Nazer R, Menning S, Tadini L, Fregni F. Inhibition of motor cortex excitability with 15Hz transcranial alternating current stimulation (tACS). Neurosci Lett. 2010 Aug 2;479(3):211-4. doi:10.1016/j.neulet.2010.05.060. Epub 2010 May 27

8. Reidler J, Nascimento B,Wu D, Carvas M,Massuyama B, de Oliveira B, Zaghi S, Rezende D, El-Nazer R, Gonçalves W, Merabet L, Fregni F. Modulation of inhibitory systems to enhance motor rehabilitation: insights for the use of noninvasive brain stimulation. Psychology & Neuroscience 3, no. 2 (2010):151-160.